Amdocs (NASDAQ:DOX – Get Free Report) will issue its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $1.43 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Amdocs (NASDAQ:DOX – Get Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.16. The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.24 billion. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. Amdocs’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.33 earnings per share. On average, analysts expect Amdocs to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.
Amdocs Stock Down 1.0 %
DOX opened at $83.99 on Wednesday. The business’s fifty day moving average is $89.38 and its two-hundred day moving average is $87.43. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market cap of $9.87 billion, a price-to-earnings ratio of 17.99, a PEG ratio of 1.38 and a beta of 0.69. Amdocs has a one year low of $78.38 and a one year high of $99.75.
Amdocs Increases Dividend
Analyst Upgrades and Downgrades
Several equities analysts recently commented on DOX shares. Barclays upped their target price on Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, February 8th. StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Friday, March 15th. Finally, Citigroup upped their price target on Amdocs from $96.00 to $104.00 and gave the stock a “buy” rating in a research note on Wednesday, January 17th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Amdocs presently has an average rating of “Buy” and an average target price of $108.60.
Get Our Latest Report on Amdocs
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- How to Use the MarketBeat Stock Screener
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Hilton Demonstrates Asset Light is Right for Investors
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.